Form 4: Integra LifeSciences SVP Disposes of Shares for Tax Withholding

Sentiment:

Insider Transaction Report


Jeffrey Mosebrook, SVP, Finance & Principal Accounting Officer at Integra LifeSciences Holdings Corp, disposed of 937 shares of common stock on July 1, 2025, to cover tax withholding obligations.

Summary

  • Jeffrey Mosebrook, the Senior Vice President, Finance & Principal Accounting Officer of Integra LifeSciences Holdings Corp (IART), reported a disposition of common stock.
  • The transaction occurred on July 1, 2025, and involved the disposition of 937 shares of common stock.
  • The disposition was executed at a price of $13.25 per share.
  • The transaction code 'F' indicates that the shares were disposed of to the issuer to satisfy tax withholding obligations.
  • Following this reported transaction, Jeffrey Mosebrook beneficially owns 39,945 shares of Integra LifeSciences Holdings Corp common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax withholding obligations, which is a neutral event and does not indicate a change in sentiment regarding the company's performance or outlook.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it pertains solely to an individual insider transaction.

Industry Context

This Form 4 filing details a routine insider transaction for tax withholding purposes and does not provide broader industry context or trends.

Related Party Transactions

  • The disposition of 937 shares was made to the issuer (Integra LifeSciences Holdings Corp) to satisfy tax withholding obligations, which is a common type of related party transaction in the context of executive compensation.

Stakeholder Impact

  • Shareholders: The disposition of 937 shares by a senior officer is a routine, small transaction that is unlikely to have a material impact on the company's stock price or overall shareholder value.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
07/01/2025Date of transaction where 937 shares of common stock were disposed of.
07/02/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Keywords

Integra LifeSciences Holdings Corp, IART, Jeffrey Mosebrook, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.